An ultrasound-based treatment for prostate cancer showed better safety and operative metrics versus robotic radical prostatectomy in an early analysis of a first-ever randomized trial. After 6 months ...
Scientists at Heriot Watt University developed a cost-effective technique for faster, more accurate prostate cancer detection using ultrasound equipment, with a 94% success rate in early trials. The ...
Study data, published in JAMA and presented at EMUC 2025, suggest ExactVu is potential MRI alternative for image-guided prostate biopsy MARKHAM, Ontario, November 19, 2025--(BUSINESS WIRE)--Exact ...
Biopsies guided by high resolution ultrasound are as effective as those using MRI in diagnosing prostate cancer, an international clinical trial has shown. The technology, called micro-ultrasound, is ...
Combining an existing small-molecule protein therapy called tumor necrosis factor related apoptosis-inducing ligand (TRAIL) with focused ultrasound (FUS) can significantly reduce tumor size and burden ...
LAS VEGAS -- Focused ultrasound ablation for prostate cancer proved at least equivalent to radical prostatectomy for failure-free survival, according to a randomized trial reported here. After 3 years ...
Researchers from Rice University and Vanderbilt University have made significant advancements in the fight against prostate cancer. They have shown that combining a small-molecule therapy called tumor ...
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...
The 'game-changing' technology proved just as effective as MRI at diagnosing the disease but was cheaper and easier to use, researchers said. It could allow doctors to provide a 'one-stop shop' where ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する